Said T K, Moraes R C, Singh U, Kittrell F S, Medina D
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Cell Growth Differ. 2001 Jun;12(6):285-95.
The level of circulating ovarian hormones (estrogen and progesterone) alone or in combination with pituitary hormones have a potent mitogenic impact in the normal mammary gland, and they also play a pivotal role in the development and progression of mammary carcinoma. The differential effects of hormones on the molecular components of cyclin-dependent kinase (cdk) complexes in mammary epithelium of the hormone-dependent ductal outgrowth line, EL11, and the hormone-independent alveolar outgrowth line, TM2L, were the focus of this study. The two outgrowth lines, which represent early stages in mammary hyperplasia, were compared with normal mammary gland at different hormonal conditions: control, hormone stimulated by pituitary isograft, and hormone depleted by ovariectomy. Hormonal stimulation by a pituitary isograft resulted in DNA synthesis and lobuloalveolar development of normal mammary ducts, DNA synthesis but no lobuloalveolar development in the EL11 ductal outgrowth, and no changes either in DNA synthesis or in lobuloalveolar morphology in the TM2L outgrowth. The levels of cdk4- and cyclin D1-associated kinase activities were correlated with cell proliferation in only the alveolar phenotypes (i.e., in only hormonally stimulated normal virgin gland and in alveolar mammary outgrowth), whereas cyclin D2-dependent kinase activity was correlated with cell proliferation in only the alveolar preneoplasia. p16(INK4a) and p21(Cip1) protein levels were decreased at the earliest stages of preneoplasia, i.e., at immortalization, and were independent from changes in cyclin D1, which occurred later in preneoplasia. Although all cdk inhibitors changed in concordance with hormonal status reflected by proliferation levels, p27(Kip1) was the only cdk inhibitor that was up-regulated at the earliest stages of preneoplasia and may have a unique role in blocking alveolar differentiation in response to the loss of one or more of the cell cycle-negative regulators. We hypothesize that up-regulation of p27(Kip1) prevents immortalized ductal outgrowths (EL11) from progressing to the neoplastic state, even under hormonal stimulation.
循环中的卵巢激素(雌激素和孕激素)单独或与垂体激素联合,对正常乳腺具有强大的促有丝分裂作用,并且它们在乳腺癌的发生和发展中也起着关键作用。本研究的重点是激素对激素依赖性导管增生系EL11和激素非依赖性肺泡增生系TM2L的乳腺上皮细胞周期蛋白依赖性激酶(cdk)复合物分子成分的不同影响。这两个增生系代表乳腺增生的早期阶段,在不同激素条件下与正常乳腺进行比较:对照、垂体同种异体移植刺激激素、卵巢切除去除激素。垂体同种异体移植刺激激素导致正常乳腺导管的DNA合成和小叶腺泡发育,EL11导管增生中有DNA合成但无小叶腺泡发育,TM2L增生中DNA合成和小叶腺泡形态均无变化。cdk4和细胞周期蛋白D1相关激酶活性水平仅与肺泡表型中的细胞增殖相关(即仅在激素刺激的正常处女腺和肺泡乳腺增生中),而细胞周期蛋白D2依赖性激酶活性仅与肺泡癌前病变中的细胞增殖相关。p16(INK4a)和p21(Cip1)蛋白水平在癌前病变的最早阶段即永生化时降低,且与细胞周期蛋白D1的变化无关,细胞周期蛋白D1的变化发生在癌前病变后期。尽管所有cdk抑制剂都与增殖水平反映的激素状态一致变化,但p27(Kip1)是唯一在癌前病变最早阶段上调的cdk抑制剂,可能在响应一种或多种细胞周期负调节因子缺失时阻断肺泡分化中发挥独特作用。我们假设,即使在激素刺激下,p27(Kip1)的上调也能阻止永生化导管增生(EL11)发展为肿瘤状态。